Powered By
Tysabri (natalizumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsing forms of multiple sclerosis.
Betaseron (interferon beta-1b) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsing forms of…
read moreLemtrada (alemtuzumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with relapsing forms of…
read moreAvonex (interferon beta 1a) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsing forms of…
read moreOcrevus (ocrelizumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with relapsing forms of multiple…
read moreBafiertam (monomethyl fumarate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with relapsing forms of multiple sclerosis (MS).
Plegridy (peginterferon beta 1a) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsing forms of multiple sclerosis in…
read moreVumerity (diroximel fumarate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsing forms of multiple sclerosis in…
read moreCopaxone (glatiramer acetate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with relapsing forms of multiple…
read moreMayzent (siponimod) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsing forms of multiple sclerosis in adults.
Join
Your Privacy Choices
